BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND TSC2, FLJ43106, 7249, ENSG00000103197, LAM, tuberin, TSC4 AND Treatment
37 results:

  • 1. [Expert consensus on the diagnosis and management of Birt-Hogg-Dubé syndrome].
    ; ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Sep; 46(9):897-908. PubMed ID: 37670643
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Primary mucosal melanomas of the urogenital tract: a clinical, pathological, and genetic nationwide survey of Danish patients 1990-2019.
    Znaider VK; Mikkelsen LH; Jensen CFS; Sønksen J; Heegaard S
    Scand J Urol; 2023 Aug; 58():52-59. PubMed ID: 37635444
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Dermatology - Update on systemic treatments for locally advanced and/or metastatic cutaneous squamous cell carcinoma].
    Brocco E
    Rev Med Suisse; 2023 Feb; 19(812):207-211. PubMed ID: 36723649
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Tuberous Sclerosis Complex: Genetic counselling and perinatal follow-up.
    Touraine R; Hauet Q; Harzallah I; Baruteau AE
    Arch Pediatr; 2022 Dec; 29(5S):5S3-5S7. PubMed ID: 36585068
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Epithelioid angiomyolipoma of the kidney after successfully treated malignant melanoma].
    Rothe H; Gaber A; Dittrich B; Nagel M; Tuffaha M; Hoschke B
    Urologe A; 2022 Feb; 61(2):183-186. PubMed ID: 34605930
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. tsc2 Interacts with HDLBP/Vigilin and Regulates Stress Granule Formation.
    Kosmas K; Filippakis H; Khabibullin D; Turkiewicz M; Lam HC; Yu J; Kedersha NL; Anderson PJ; Henske EP
    Mol Cancer Res; 2021 Aug; 19(8):1389-1397. PubMed ID: 33888601
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Everolimus treatment in a 3-month-old infant with tuberous sclerosis complex cardiac rhabdomyoma, severe left ventricular outflow tract obstruction, and hearing loss.
    Çetin M; Aydın AA; Karaman K
    Cardiol Young; 2021 Aug; 31(8):1359-1362. PubMed ID: 33658088
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Natural history of a fibrous cephalic plaque and sustained eight decade follow-up in an 80 year old with tuberous sclerosis complex type 2.
    Kirk CW; Donnelly DE; Hardy R; Shepherd CW; Morrison PJ
    Ulster Med J; 2020 Jan; 89(1):14-16. PubMed ID: 32218621
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Immunotherapy for Lymphangioleiomyomatosis and Tuberous Sclerosis: Progress and Future Directions.
    Liu HJ; Krymskaya VP; Henske EP
    Chest; 2019 Dec; 156(6):1062-1067. PubMed ID: 31437431
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Familial Kidney cancer: Implications of New Syndromes and Molecular Insights.
    Carlo MI; Hakimi AA; Stewart GD; Bratslavsky G; Brugarolas J; Chen YB; Linehan WM; Maher ER; Merino MJ; Offit K; Reuter VE; Shuch B; Coleman JA
    Eur Urol; 2019 Dec; 76(6):754-764. PubMed ID: 31326218
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Renal disease in tuberous sclerosis complex: pathogenesis and therapy.
    Lam HC; Siroky BJ; Henske EP
    Nat Rev Nephrol; 2018 Nov; 14(11):704-716. PubMed ID: 30232410
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [
    Verwer EE; Kavanagh TR; Mischler WJ; Feng Y; Takahashi K; Wang S; Shoup TM; Neelamegam R; Yang J; Guehl NJ; Ran C; Massefski W; Cui Y; El-Chemaly S; Sadow PM; Oldham WM; Kijewski MF; El Fakhri G; Normandin MD; Priolo C
    Clin Cancer Res; 2018 Dec; 24(23):5925-5938. PubMed ID: 30054282
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cutaneous Manifestations of Tuberous Sclerosis.
    Bakić M; Ratković M; Gledović B; Vujović B; Radunović D; Babić V; Prelević V
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):73-74. PubMed ID: 29782307
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Novel enriched pathways in superficial malignant peripheral nerve sheath tumours and spindle/desmoplastic melanomas.
    Jour G; Andeen NK; Al-Rohil R; Aung PP; Mehrotra M; Duose D; Hoch B; Argenyi Z; Luthra R; Wistuba II; Prieto VG
    J Pathol; 2018 Jan; 244(1):97-106. PubMed ID: 28991373
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies.
    Keppler-Noreuil KM; Parker VE; Darling TN; Martinez-Agosto JA
    Am J Med Genet C Semin Med Genet; 2016 Dec; 172(4):402-421. PubMed ID: 27860216
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Applying the Lessons of Tuberous Sclerosis: The 2015 Hower Award Lecture.
    Roach ES
    Pediatr Neurol; 2016 Oct; 63():6-22. PubMed ID: 27543366
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Tuberous sclerosis complex.
    Henske EP; Jóźwiak S; Kingswood JC; Sampson JR; Thiele EA
    Nat Rev Dis Primers; 2016 May; 2():16035. PubMed ID: 27226234
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex.
    MacKeigan JP; Krueger DA
    Neuro Oncol; 2015 Dec; 17(12):1550-9. PubMed ID: 26289591
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Pulmonary choriostoma in a case of tuberous sclerosis complex.
    Spalgais S; Gothi D; Verma AK
    J Postgrad Med; 2015; 61(3):193-6. PubMed ID: 26119439
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Comparison of Akt/mTOR/4E-BP1 pathway signal activation and mutations of PIK3CA in Merkel cell polyomavirus-positive and Merkel cell polyomavirus-negative carcinomas.
    Iwasaki T; Matsushita M; Nonaka D; Kuwamoto S; Kato M; Murakami I; Nagata K; Nakajima H; Sano S; Hayashi K
    Hum Pathol; 2015 Feb; 46(2):210-6. PubMed ID: 25466966
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.